Normal view MARC view ISBD view

Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease.

O'Toole, Aoibhlinn

Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease. [electronic resource] - Current gastroenterology reports Aug 2015 - 32 p. digital

Publication Type: Journal Article; Review

ISSN: 1534-312X

Standard No.: 10.1007/s11894-015-0453-1 doi

Subjects--Topical Terms:
Adalimumab--therapeutic use
Biological Factors--therapeutic use
Colitis, Ulcerative--drug therapy
Crohn Disease--drug therapy
Drug Monitoring--methods
Drug Substitution
Evidence-Based Medicine--methods
Humans
Infliximab--therapeutic use

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)